Nervous system Lyme disease

Journal of the Neurological Sciences

Volumn 153, Issue 2, 1998, Pages 182-191

  Halperin, John J ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Cranial neuropathies; Encephalomyelitis; Erythema migrans; Facial palsy; Lyme arthritis; Lyme disease; Meningitis; Neuroborreliosis; Peripheral neuropathy

Indexed keywords

DOXYCYCLINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY PRODUCTION; BORRELIA BURGDORFERI; COGNITION; DISEASE TRANSMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYME DISEASE; MEMORY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

EID: 0032495510     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00290-6     Document Type: Article

References (69)

1. Steere A.C., Malawista S.E., Hardin J.A., Ruddy S., Askenase W., Andiman W.A. Erythema chronicum migrans and Lyme arthritis - The enlarging clinical spectrum. Ann. Intern. Med. 86:1977;685-698.
2. Garin B. Paralysie par les tiques. J. Med. (Lyon). 71:1922;765-767.
3. Steere A.C., Grodzicki R.L., Kornblatt A.N.et al. The spirochetal etiology of Lyme Disease. N. Engl. J. Med. 308:1983;733-740.
4. Benach J.L., Bosler E.M., Hanrahan J.P.et al. Spirochetes isolated from the blood of two patients with Lyme Disease. N. Engl. J. Med. 308:1983;740-742.
5. Asbrink E., Hederstedt B., Hovmark A. The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm. Venereol. 64:1984;506-512.
6. Afzelius A. Erythema chronicum migrans. Acta Derm. Venereol. (Stockholm). 2:1921;120-125.
7. Bannwarth A. Chronische lymphocytare meningitis,entzundliche polyneuritis und 'rheumatismus'. Arch. Psychiatr. Nervenkr. 113:1941;284-376.
8. Reik L., Steere A.C., Bartenhagen N.H., Shope R.E., Malawista S.E. Neurologic abnormalities of Lyme disease. Medicine. 58:1979;281-294.
9. Karlsson M., Hovind H.K., Svenungsson B., Stiernstedt G. Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lym borreliosis. J. Clin. Microbiol. 28:1990;473-479.
10. Kaell A.T., Volkman D.J., Gorevic P.D., Dattwyler R.J. Positive Lyme serology in subacute bacterial endocarditis. A study of four patients. JAMA. 264:1990;2916-2918.
11. Morbidity Mortality Weekly Report, 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 44, 590-591.
12. Ledue T.B., Collins M.F., Craig W.Y. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J. Clin. Microbiol. 34:1996;2343-2350.
13. Dressler F., Whalen J.A., Reinhardt B.N., Steere A.C. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167:1993;392-400.
14. Dattwyler R.J., Volkman D.J., Luft B.J., Halperin J.J., Thomas J., Golightly M.G. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N. Engl. J. Med. 319:1988;1441-1446.
15. Logigian E.L., McHugh G.L., Steere A.C. Antibiotics for early Lyme disease may prevent full seroconversion but not CNS infection. Neurology. 48:1997;A388-A389.
16. Rosa P.A., Schwan T.G. A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J. Infect. Dis. 160:1989;1018-1029.
17. Keller T.L., Halperin J.J., Whitman M. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology. 42:1992;32-42.
18. Nocton J.J., Bloom B.J., Rutledge B.J.et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J. Infect. Dis. 174:1996;623-627.
19. Nocton J.J., Dressler F., Rutledge B.J., Rys P.N., Persing D.H., Steere A.C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Eng. J. Med. 1994:1994;229-234.
20. Noordhoek G.T., Wolters E.C., deJonge M.E.J., VanEmbden J.D.A. Detection by polymerase chain reaction of Treponema pallidum DNA in cerebrospinal fluid from Halperin, Lyme disease neurosyphilis patients before and after antibiotic treatment. J. Clin. Microbiol. 29:1991;1776-1784.
21. Hyde F.W., Johnson R.C., White T.J., Shelburne C.E. Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J. Clin. Microbiol. 27:1989;58-61.
22. Coyle P.K., Schutzer S.E., Deng Z.et al. Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease. Neurology. 45:1995;2010-2015.
23. Coyle P.K., Deng Z., Schutzer S.E.et al. Detection of Borrelia burgdorferi antigens in cerebrospinal fluid. Neurology. 43:1993;1093-1097.
24. Stiernstedt G.T., Granstrom M., Hederstedt B., Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J. Clin. Microbiol. 21:1985;819-825.
25. Wilske B., Schierz G., Preac-Mursic V.et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis. J. Infect. Dis. 153:1986;304-314.
26. Halperin J.J., Luft B.J., Anand A.K.et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology. 39:1989;753-759.
27. Steere A.C., Berardi V.P., Weeks K.E., Logigian E.L., Ackermann R. Evaluation of the Intrathecal Antibody Response to Borrelia burgdorferi as a Diagnostic Test for Lyme Neuroborreliosis. J. Infect. Dis. 161:1990;1203-1209.
28. Halperin J.J., Volkman D.J., Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 41:1991;1571-1582.
29. Logigian E.L., Kaplan R.F., Steere A.C. Chronic neurologic manifestations of Lyme disease. N. Engl. J. Med. 323:1990;1438-1444.
30. Hopf H.C. Peripheral neuropathy in acrodermatitis chronica atrophicans. J. Neurol. Neurosurg. Psychiatry. 38:1975;452-458.
31. Halperin J.J., Luft B.J., Volkman D.J., Dattwyler R.J. Lyme neuroborreliosis-peripheral nervous system manifestations. Brain. 113:1990;1207-1221.
32. England J.D., Bohm R.P., Roberts E.D., Philipp M.T. Mononeuropathy multiplex in rhesus monkeys with chronic Lyme disease. Ann. Neurol. 41:1997;375-384.
33. Camponovo F., Meier C. Neuropathy of vasculitic origin in a case of Garin-Bujadoux-Bannwarth syndrome with positive Borrelia antibody response. J. Neurol. 233:1986;69-72.
34. Vallat J.M., Hugon J., Lubeau M., Leboutet M.J., Dumas M., Desproges-Gotteron R. Tick bite meningoradiculoneuritis. Neurology. 37:1987;749-753.
35. Ackermann R., Rehse K.B., Gollmer E., Schmidt R. Chronic neurologic manifestations of erythema migrans borreliosis. Ann. N.Y. Acad. Sci. 539:1988;16-23.
36. Halperin J.J., Little B.W., Coyle P.K., Dattwyler R.J. Lyme disease-a treatable cause of peripheral neuropathy. Neurology. 37:1987;1700-1706.
37. Atlas E., Novak S.N., Duray P.H., Steere A.C. Lyme myositis: muscle invasion by Borrelia burgdorferi. Ann. Intern. Med. 109:1988;245-246.
38. Horowitz H.W., Sanghera K., Goldberg N.et al. Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis. Clin. Infect. Dis. 18:1994;166-171.
39. Ackermann R., Gollmer E., Rehse K.B. Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system. Dtsch. Med. Wochenschr. 110:1985;1039-1042.
40. Halperin J.J., Pass H.L., Anand A.K., Luft B.J., Volkman D.J., Dattwyler R.J. Nervous system abnormalities in Lyme disease. Ann. N.Y. Acad. Sci. 539:1988;24-34.
41. Halperin J.J., Krupp L.B., Golightly M.G., Volkman D.J. Lyme borreliosis-associated encephalopathy. Neurology. 40:1990;1340-1343.
42. Krupp L.B., Fernquist S., Masur D., Halperin J.J. Cognitive impairment in Lyme Disease. Neurology. 40:1990;304.
43. Kaplan R.F., Meadows M.E., Vincent L.C., Logigian E.L., Steere A.C. Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology. 42:1992;1263-1267.
44. Benke T., Gasse T., Hittmair-Delazer M., Schmutzhard E. Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis. Acta Neurol. Scand. 91:1995;353-357.
45. Halperin J.J., Heyes M.P. Neuroactive kynurenines in Lyme borreliosis. Neurology. 42:1992;43-50.
46. Krupp L.B., Masur D., Schwartz J.et al. Cognitive functioning in late Lyme borreliosis. Arch. Neurol. 48:1991;1125-1129.
47. May E.F., Jabbari B. Stroke in neuroborreliosis. Stroke. 21:1990;1232-1235.
48. Uldry P.A., Regli F., Bogousslavsky J. Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection. J. Neurol. Neurosurg. Psychiatry. 50:1987;1703-1704.
49. Hammers-Berggren S., Grondahl A., Karlsson M., Von A.M., Carlsson A., Stiernstedt G. Screening for neuroborreliosis in patients with stroke. Stroke. 24:1993;1393-1396.
50. Halperin J.J., Kaplan G.P., Brazinsky S.et al. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch. Neurol. 47:1990;586-594.
51. Fredrikson S., Link H. CNS-borreliosis selectively affecting central motor eurons. Acta Neurol. Scand. 78:1988;181-184.
52. Scelsa S.N., Herskovitz S., Berger A.R. A predominantly motor polyradiculopathy of Lyme disease. Muscle Nerve. 19:1996;780-783.
53. Oksi J., Kalimo H., Marttila R.J.et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain. 119:1996;2143-2154.
54. Pachner A.R., Delaney E., O'Neill T., Major E. Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease. Neurology. 45:1995;165-172.
55. Garcia Monco J.C., Villar B.F., Alen J.C., Benach J.L. Borrelia burgdorferi in the Central Nervous System: Experimental and Clinical Evidence for Early Invasion. J. Infect. Dis. 161:1990;1187-1193.
56. Luft B.J., Steinman C.R., Neimark H.C.et al. Invasion of the Central Nervous System by Borrelia burgdorferi in Acute Disseminated Infection. JAMA. 267:1992;1364-1367.
57. Garcia Monco J.C., Fernandez-Villar B., Benach J.L. Adherence of the Lyme disease spirochete to glial cells and cells of glial origin. J. Infect. Dis. 160:1989;497-506.
58. Garcia Monco J.C., Fernandez V.B., Rogers R.C., Szczepanski A., Wheeler C.M., Benach J.L. Borrelia burgdorferi and other related spirochetes bind to galactocerebroside. Neurology. 42:1992;1341-1348.
59. Coyle P.K., Schutzer S.E., Belman A.L., Krupp L.B., Golightly M.G. Cerebrospinal fluid immune complexes in patients exposed to Borrelia burgdorferi: detection of Borrelia-specific and -nonspecific complexes. Ann. Neurol. 28:1990;739-744.
60. Sigal L.H. Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64 000 molecular weight protein. J. Infect. Dis. 167:1993;1372-1378.
61. Strle F., Preac M.V., Cimperman J., Ruzic E., Maraspin V., Jereb M. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological tindings. Infection. 21:1993;83-88.
62. Dattwyler R.J., Volkman D.J., Conaty S.M., Platkin S.P., Luff B.J. Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet. 336:1990;1404-1406.
63. Bale J.F.J., Murph J.R. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann. Intern. Med. 117:1992;273-280.
64. Steere A.C., Levin R.E., Molloy P.J.et al. Treatment of Lyme arthritis. Arthritis. Rheum. 37:1994;878-888.
65. Dattwyler, R.J., Halperin, J.J., Volkman, D.J., Luft, B.J., 1988. Treatment of late Lyme disease. Volume I. Lancet 1191-1193.
66. Pfister H.W., Preac M.V., Wilske B., Einhaupl K.M. Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis - A prospective randomized study. Arch. Neurol. 46:1989;1190-1194.
67. Pfister H.W., Preac Mursic V., Wilske B., Schielke E., Sorgel F., Einhaupl K.M. Randomized Comparison of Ceftriaxone and Cefotaxime in Lyme Neuroborreliosis. J. Infect. Dis. 163:1991;311-318.
68. Karlsson M., Hammers-Berggren S., Lindquist L., Stiernstedt G., Svenungsson B. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology. 44:1994;1203-1207.
69. Dattwyler, R.J., Luft, B.J., Maladorno, D., et al., 1986. Treatment of late Lyme disease-a comparison of 2 weeks vs 4 weeks of ceffriaxone. VII International Congress on Lyme Borreliosis. San Francisco, Ca., p. 186.